Douglas Ammerman Biography and Net Worth

Director of F&G Annuities & Life

Douglas Keith Ammerman serves as Independent Director of the Company. Mr. Ammerman has also served as a director of FNF since July 2005. Mr. Ammerman is a retired partner of KPMG LLP, where he became a partner in 1984. Mr. Ammerman formally retired from KPMG LLP in 2002. Additionally, he currently serves as a director of Stantec Inc. Within the past five years, Mr. Ammerman also has served as a director of Remy International, El Pollo Loco, Inc. and William Lyon Homes, Inc. As a member of our Board, Mr. Ammerman contributes his significant financial and accounting background and expertise, including his 18 years as a partner with KPMG LLP and his experience as a director on the boards of directors of other companies.

What is Douglas K. Ammerman's net worth?: The estimated net worth of Douglas K. Ammerman is at least $1.18 million as of May 8th, 2023. Mr. Ammerman owns 30,145 shares of F&G Annuities & Life stock worth more than $1,176,559 as of April 27th. This net worth approximation does not reflect any other investments that Mr. Ammerman may own. Learn More about Douglas K. Ammerman's net worth.
How do I contact Douglas K. Ammerman?: The corporate mailing address for Mr. Ammerman and other F&G Annuities & Life executives is 4th Floor Boundary Hall Cricket Square, Grand Cayman E9, KY1-1102. F&G Annuities & Life can also be reached via phone at 515-330-3340 and via email at [email protected]. Learn More on Douglas K. Ammerman's contact information.
Has Douglas K. Ammerman been buying or selling shares of F&G Annuities & Life?: Douglas K. Ammerman has not been actively trading shares of F&G Annuities & Life during the past quarter. Most recently, on Monday, May 8th, Douglas K. Ammerman bought 12,004 shares of F&G Annuities & Life stock. The stock was acquired at an average cost of $16.80 per share, with a total value of $201,667.20. Following the completion of the transaction, the director now directly owns 30,145 shares of the company's stock, valued at $506,436. Learn More on Douglas K. Ammerman's trading history.
Who are F&G Annuities & Life's active insiders?: F&G Annuities & Life's insider roster includes Douglas Ammerman (Director), and Christopher Blunt (CEO). Learn More on F&G Annuities & Life's active insiders.
Are insiders buying or selling shares of F&G Annuities & Life?: During the last year, F&G Annuities & Life insiders bought shares 2 times. They purchased a total of 17,004 shares worth more than $333,567.20. The most recent insider tranaction occured on October, 3rd when CEO Christopher O Blunt bought 5,000 shares worth more than $131,900.00. Insiders at F&G Annuities & Life own 1.5% of the company. Learn More about insider trades at F&G Annuities & Life.
Information on this page was last updated on 10/3/2023.

Douglas K. Ammerman Insider Trading History at F&G Annuities & Life

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/8/2023	Buy	12,004	$16.80	$201,667.20	30,145

Douglas K. Ammerman Buying and Selling Activity at F&G Annuities & Life

F&G Annuities & Life Company Overview

F&G Annuities & Life, Inc. provides fixed annuities and life insurance products in the United States. The company portfolio includes fixed indexed annuities, multi-year guarantee annuities, and pension risk transfer solution, as well as indexed universal life insurance, institutional funding agreements, and index-linked annuities. It serves retail annuity and life customers, as well as institutional clients. The company was founded in 1959 and is headquartered in Des Moines, Iowa. F&G Annuities & Life, Inc. operates as a subsidiary of Fidelity National Financial, Inc.

Today's Range

Now: $39.03

$38.68

$39.61

50 Day Range

MA: $38.75

$35.11

$44.57

2 Week Range

Now: $39.03

$14.76

$48.71

Volume

64,271 shs

Average Volume

105,725 shs

Market Capitalization

$4.93 billion

P/E Ratio

N/A

Dividend Yield

2.17%

Beta

1.21

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>